Compare SAN & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SAN | SYK |
|---|---|---|
| Founded | 1857 | 1941 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.1B | 141.2B |
| IPO Year | 1987 | N/A |
| Metric | SAN | SYK |
|---|---|---|
| Price | $11.85 | $355.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 15 |
| Target Price | N/A | ★ $432.13 |
| AVG Volume (30 Days) | ★ 2.6M | 1.6M |
| Earning Date | 02-04-2026 | 01-27-2026 |
| Dividend Yield | ★ 1.56% | 0.99% |
| EPS Growth | ★ 14.58 | N/A |
| EPS | 1.00 | ★ 7.61 |
| Revenue | ★ $59,455,590,761.00 | $24,381,000,000.00 |
| Revenue This Year | $23.33 | $11.98 |
| Revenue Next Year | N/A | $8.60 |
| P/E Ratio | ★ $11.19 | $46.61 |
| Revenue Growth | 8.72 | ★ 10.95 |
| 52 Week Low | $4.43 | $329.16 |
| 52 Week High | $11.88 | $406.19 |
| Indicator | SAN | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 73.61 | 43.50 |
| Support Level | $11.49 | $349.55 |
| Resistance Level | $11.78 | $359.81 |
| Average True Range (ATR) | 0.15 | 6.01 |
| MACD | 0.04 | 0.17 |
| Stochastic Oscillator | 98.95 | 35.65 |
Santander's focus is on retail and commercial banking. Latin America is geographically the most significant operation, with Brazil making the largest contribution. Its continental European business is mainly in Spain and Portugal. Santander's UK presence is the result of its acquisition of Abbey building society. In the US, Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.